Annual Event Post | Calendar of Events

In the past five years, as a leading meeting place for drug discovery in Pacific Rim Region, IDDST, initiated by BIT Life Sciences, has attracted more than 700 world renowned speakers with participants over 40,000 professionals from all over the world, including world leading scientists including 18 Nobel Prize Laureates., senior executives, entrepreneurs, investors and regulatory policy makers.

IDDST 2008 will offer an Olympian gathering to emphasize the pioneer explorations of basic research and technology development across therapeutic areas, to update current status all phase drug discovery and development timely. The program will also provide a profound coverage on global trend of R & D of innovative therapeutics in relation with major disease areas. Numerous Sessions cover pipeline transfer strategy and licensing, CRO and CMO in China. Through IDDST 2008, you will also gain deep insight into the strategies of major pharma players in integrating scientific, technological, talent and business resources in a flat world to increase business competitive capacities. You will also enjoy the Joint Symposium on Frontier of Medicinal Chemistry sponsored by ACS Medchem Division.

For IDDST 2008, BIT Life Sciences plans to include:

u 10+Top-Ranking Plenary Speakers Including Nobel Prize Laureates and Industrial Leaders

u 6 Tracks with 60+ Optional Workshops Focusing on Drug Discovery and Development

u 500+ Brilliant Scientific, tech and Business Presentations offering You Brainstorms

u 100+ Scientific Posters Presenting Exciting Research Achievements

u 100+ Exhibition Booths Showcasing New Products and New Technologies

u 100+Business Plan and Investment Opportunities Catching Latest Trend in Drug Discovery

u 1500+ Attendees coming from Worldwide to Exchange Ideas, Build new network and foster friendship

u A colorful Tech Tour to Ancient Cities, Beijing and Xian leading you to enjoy 5000 years of Chinese historical miracles, amazing culture events and delicious foods

Plan now to attend and share your excitement in innovation of therapeutics at IDDST 2008!

For more details about the IDDST 2008, PS: http://www.iddst.com/iddst2008/index.htm

We look forward to meeting you in this grand event of drug discovery in golden October, 2008, in Beijing, China.

Best Regards,

Ms. Mary Dong,
Program Coordinator
Organizing Committee of IDDST-2008
26 Gaoneng St., F4
Dalian Hightech Zone
Dalian, LN 116025, China
Tel: 0086-411-84799609 ext. 810
Fax: 0086-411-84799629

Website at: http://www.iddst.com/iddst2008
Email: mary@iddst.com

-------------------------------------------------------------

Scientific Program--Six Remarkable Tracks

-------------------------------------------------------------

Track 1: Drug Discovery Sciences
-Great Thoughts for Deciphering Human Disorders

Session 1: “-Omics”, Molecular Genetics to System Biology in Drug Discovery
Session 2: Regenerative Medicine in Drug Discovery
Session 3: Molecular/Cell Biology and Drug Discovery
Session 4: Immunology and Drug Discovery
Session 5: Oncology and Drug Discovery
Session 6: Microbiology, Virology in Drug Discovery
Session 7: Neurology in Drug Discovery
Session 8: Hepatology in Drug Discovery
Session 9: Endocrinology in Drug Discovery
Session 10: Pharmacology,Toxicology and Pathology in Drug Discovery
Session 11: Protein/Peptide Sciences, and Protein-Protein Interactions
Session 12: Molecular Targets and Biomarkers in Drug Discovery
Session 13: Cytokine based Drug Discovery
Session 14: Protein to Cell Based Assay Technologies
Session 15: Nuclear Receptors and Drug Discovery
Session 16: Proteinase and Kinases in Drug Discovery
Session 17: G Protein-Coupled Receptors in Drug Discovery
Session 18: Targeting Signaling Pathways
Session 19: Laboratory Animals in Drug Discovery
Session 20: Clinical Trials Methodologies

Track 2: Frontiers in Medicinal Chemistry
-Build Better Drug Molecules at Atomic-Level

Special Symposium Sponsored by ACS-Medichem Division

Medicinal Chemistry Part 1: Plenary Lectures

-- From Novel Targets to Billion Dollar Molecules

Medicinal Chemistry Part II: Parallel Sessions

Session 21: Modeling, SAR and Synthesis
Session 22: Combinatorial and High Throughput Synthetic Chemistry
Session 23: Target Identification and Lead Optimization
Session 24: Microfluidics and Nanoscale Synthesis
Session 25: Case Studies of Better Drugs through Medicinal Chemistry

Track 3: Drug Discovery Technologies
-Speeding Discovery Process with Niches

Session 26: RNAi, MicroRNA, and Non-Coding RNA Technologies
Session 27: Bioinformatics, Bio-IT, LIMS to Data Visualization in Drug Discovery
Session 28: Computer Aided Drug Design and Fragment-Based Discovery
Session 29: Multiple Read-Out Options, Biochips, Microarray, Electrophoresis, Lab-on-Chips and Lab Automation
Session 30: High Throughput/Content and Virtual Screening
Session 31: Technologies from Enzyme to Cell Based Assays
Session 32: Translational Medicines
Session 33: LC, LC-MS, NMR and X-ray Crystallography in Drug Discovery
Session 34: Safety Evaluation Tech: From ADME-Tox Screening to Clinical Trials
Session 35: Nanotechnologies and Novel Drug Delivery Technologies

Track 4: Therapeutics Development for Diseases
-Delivering Promises for Future Drugs

Section 4-1: Drug Discovery and Development against Major Diseases
Session 36: Anti-Emerging Disease Drug Discovery and Development
Session 37: Cancer Therapeutics Discovery and Development
Session 38: CNS Disorder Drug Discovery and Development
Session 39: Anti-HIV Drug Discovery and Development
Session 40: Anti-HCV Drug Discovery and Development
Session 41: HPV and Other Antiviral Drug Discovery and Development
Session 42: Antifungal Drug Discovery and Development
Session 43: Cardiovascular Drug Discovery and Development
Session 44: Neurodegenerative Diseases Drug Discovery and Development
Session 45: Metabolic Diseases Drug Discovery and Development
Session 46: Asthma/COPD Drug Discovery and Development
Session 47: Autoimmune Disorder Drug Discovery and Development
Session 48: Anti-Allergy Drug Discovery and Development
Session 49: MDR Drug Resistant Bacterial/Parasite Infections, TB and Malaria
Session 50: Drug Discovery and Development against Severe Gastrointestinal Disorders
Section 4-2: Novel Biopharmaceutical Drug Discovery and Development
Session 51: Novel Regenerative Medicine Therapeutics and Stem Cell Therapies
Session 52: Alternative Cell Therapeutics Discovery and Development
Session 53: Therapeutic Monoclonal Antibody Development
Session 54: New Preventive and Therapeutic Vaccine Discovery and Development
Session 55: Gene Therapeutics/Nucleic Acid Based Drug Discovery and Development

Track 5: Nature Product Based Drug Discovery
-Mining 5000 Year Nature Pool

Session 56: Apply Cutting edge Technologies For Modernization of TCM
Session 57: Rethink TCM in System Biology and Multi-Target Theory
Session 58: Mining Hits and Leads using TCM as Super Natural Compound Library
Session 59: Develop Bioprocesses for Production of High Value Natural Medicines
Session 60: Establish Standardized and Quantitative TCM Formulation

Track 6: Drug R & D Partnering in China
-Integrating Resources from the East

Session 61: Drug R & D Licensing and Partnering in China-From CRO to FTE
Session 62: Find your CMO by Integrating China Tech Resources for Cost Effective Biologics
Session 63: Huge Talent Chemist Pool for Outsourcing Medicinal Chemistry
Session 64: Increase Your Labor Threshold of Preclinical and Clinical Trials in China
Session 65: Joint Venture on Screening Natural Formulation from Efficacy Validated TCM

Website at: http://www.iddst.com/iddst2008/index.htm